Linical is a dominant, publicly-traded, medium-sized CRO with a substantial presence throughout the United States, Europe, and Asia-Pacific. Linical serves as a global partner for comprehensive drug development, uniquely equipped to carry out extensive, international research projects while providing tailored, hands-on support. Our specialized areas encompass clinical trials in oncology, vaccines, infectious diseases, CNS, and general medicine from Phase I-IV.